Back

Heterogeneity in the response to angiotensin receptor-neprilysin inhibitors on ventricular arrhythmogenicity and sympathetic tone activation

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - Highlights in multimodality imaging Imaging of Heart Failure ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Raffaele De Caterina

University of Pisa, Pisa (Italy)

7 More presentations in this session

Presentation thumbnail
Discussant - Highlights in multimodality imaging
Presentation thumbnail
Impact of computed tomography-defined iliac vein compression on recurrent deep vein thrombosis
Doctor P. Chen (Tainan, TW)
Abstract
Presentation thumbnail
Prediction of poor prognosis in patients with AMI after PCI based on a magnetocardiography diagnostic model for microvascular injury
Doctor H. Shen (Shanghai, CN)
Abstract
Presentation thumbnail
Association between abnormal fatty acid metabolism and myocardial triglyceride accumulation in patients with chronic heart failure: a study using BMIPP and 1H-MRS
Doctor A. Kudo (Tokyo, JP)
Abstract
Presentation thumbnail
Can cardiac magnetic resonance imaging safely defer invasive coronary angiography in patients with suspected non-ST-elevation myocardial infarction?
Doctor D. Andersson (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (1) - Highlights in multimodality imaging

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Short-term effects on sacubitril/valsartan therapy on right ventricle work and mechanics in patients with heart failure and reduced ejection fraction
thumbnail
Congress Presentation
Cardiac sympathetic innervation, assessed with 123I-MIBG SPECT, predicts left ventricular function improvement in patients with newly diagnosed dilated cardiomyopathy
thumbnail
Congress Presentation
Treatment with sacubitril/valsartan and improvement of ventricular-arterial coupling in heart failure with reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources